{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:28:13Z","timestamp":1788607693705,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008557","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T18:51:45Z","timestamp":1510167105000},"page":"e8557","source":"Crossref","is-referenced-by-count":18,"title":["Volume-based metabolic parameter of breast cancer on preoperative 18F-FDG PET\/CT could predict axillary lymph node metastasis"],"prefix":"10.1097","volume":"96","author":[{"given":"Young-Sil","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doo Kyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsik","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-68-20210309","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/cncr.21659","article-title":"Twenty-five years of follow-up in patients with operable breast carcinoma: correlation between clinicopathologic factors and the risk of death in each 5-year period","volume":"106","author":"Arriagada","year":"2006","journal-title":"Cancer"},{"key":"R2-68-20210309","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10549-007-9556-1","article-title":"An overview of prognostic factors for long-term survivors of breast cancer","volume":"107","author":"Soerjomataram","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"R3-68-20210309","doi-asserted-by":"crossref","first-page":"e3689","DOI":"10.1097\/MD.0000000000003689","article-title":"Simple prediction model of axillary lymph node positivity after analyzing molecular and clinical factors in early breast cancer","volume":"95","author":"Chung","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R4-68-20210309","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4143\/crt.2010.42.1.30","article-title":"Predictors of axillary lymph node metastases (ALNM) in a Korean population with T1-2 breast carcinoma: triple negative breast cancer has a high incidence of ALNM irrespective of the tumor size","volume":"42","author":"Lee","year":"2010","journal-title":"Cancer Res Treat"},{"key":"R5-68-20210309","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/cncr.20809","article-title":"Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution","volume":"103","author":"Viale","year":"2005","journal-title":"Cancer"},{"key":"R6-68-20210309","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/annonc\/mdm268","article-title":"Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer","volume":"18","author":"Colleoni","year":"2007","journal-title":"Ann Oncol"},{"key":"R7-68-20210309","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.breast.2012.09.003","article-title":"Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice","volume":"22","author":"Yoshihara","year":"2013","journal-title":"Breast"},{"key":"R8-68-20210309","doi-asserted-by":"crossref","first-page":"W630","DOI":"10.2214\/AJR.14.14269","article-title":"The breast tumor strain ratio is a predictive parameter for axillary lymph node metastasis in patients with invasive breast cancer","volume":"205","author":"Kim","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"R9-68-20210309","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/s00330-014-3452-y","article-title":"Tumour 18 F-FDG Uptake on preoperative PET\/CT may predict axillary lymph node metastasis in ER-positive\/HER2-negative and HER2-positive breast cancer subtypes","volume":"25","author":"Kim","year":"2015","journal-title":"Eur Radiol"},{"key":"R10-68-20210309","first-page":"120","article-title":"Prognostic value of FDG PET\/CT-based metabolic tumor volumes in metastatic triple negative breast cancer patients","volume":"6","author":"Marinelli","year":"2016","journal-title":"Am J Nucl Med Mol Imaging"},{"key":"R11-68-20210309","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MNM.0000000000000217","article-title":"Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer","volume":"36","author":"Kaj\u00e1ry","year":"2015","journal-title":"Nucl Med Commun"},{"key":"R12-68-20210309","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2967\/jnumed.115.158287","article-title":"18F-FDG PET\/CT to predict response to neoadjuvant chemotherapy and prognosis in inflammatory breast cancer","volume":"56","author":"Champion","year":"2015","journal-title":"J Nucl Med"},{"key":"R13-68-20210309","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1002\/cncr.29565","article-title":"Risk stratification in patients with advanced-stage breast cancer by pretreatment [(18) F]FDG PET\/CT","volume":"121","author":"Chen","year":"2015","journal-title":"Cancer"},{"key":"R14-68-20210309","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1148\/radiol.2015141638","article-title":"Early metabolic response to neoadjuvant treatment: FDG PET\/CT Criteria according to breast cancer subtype","volume":"277","author":"Groheux","year":"2015","journal-title":"Radiology"},{"key":"R15-68-20210309","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1148\/radiol.14141129","article-title":"Volume-based metabolic tumor response to neoadjuvant chemotherapy is associated with an increased risk of recurrence in breast cancer","volume":"275","author":"Hyun","year":"2015","journal-title":"Radiology"},{"key":"R16-68-20210309","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s13139-012-0161-9","article-title":"Prognostic significance of metabolic tumor volume measured by (18)F-FDG PET\/CT in operable primary breast cancer","volume":"46","author":"Kim","year":"2012","journal-title":"Nucl Med Mol Imaging"},{"key":"R17-68-20210309","doi-asserted-by":"crossref","first-page":"e4605","DOI":"10.1097\/MD.0000000000004605","article-title":"Value of volume-based metabolic parameters for predicting survival in breast cancer patients treated with neoadjuvant chemotherapy","volume":"95","author":"Kim","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R18-68-20210309","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/RLU.0000000000000531","article-title":"Value of 18F-FDG PET\/CT for early prediction of pathologic response (by residual cancer burden criteria) of locally advanced breast cancer to neoadjuvant chemotherapy","volume":"39","author":"Lee","year":"2014","journal-title":"Clin Nucl Med"},{"key":"R19-68-20210309","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2214\/AJR.14.13906","article-title":"Whole-body metabolic tumor volume, as determined by (18)F-FDG PET\/CT, as a prognostic factor of outcome for patients with breast cancer who have distant metastasis","volume":"205","author":"Son","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"R20-68-20210309","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10549-015-3558-1","article-title":"Stratifying triple-negative breast cancer prognosis using 18F-FDG-PET\/CT imaging","volume":"153","author":"Yue","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"R21-68-20210309","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/cam4.119","article-title":"Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer","volume":"2","author":"Ulaner","year":"2013","journal-title":"Cancer Med"},{"key":"R22-68-20210309","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00259-006-0363-4","article-title":"A gradient-based method for segmenting FDG-PET images: methodology and validation","volume":"34","author":"Geets","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R23-68-20210309","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.ijrobp.2010.12.055","article-title":"What is the best way to contour lung tumors on PET scans? Multiobserver validation of a gradient-based method using a NSCLC digital PET phantom","volume":"82","author":"Werner-Wasik","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R24-68-20210309","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4143\/crt.2015.172","article-title":"(18)F-FDG\/PET may help to identify a subgroup of patients with T1-T2 breast cancer and 1-3 positive lymph nodes who are at a high risk of recurrence after mastectomy","volume":"48","author":"Chang","year":"2016","journal-title":"Cancer Res Treat"},{"key":"R25-68-20210309","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R26-68-20210309","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2407-7-134","article-title":"Use of immunohistochemical markers can refine prognosis in triple negative breast cancer","volume":"7","author":"Tischkowitz","year":"2007","journal-title":"BMC Cancer"},{"key":"R27-68-20210309","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.22381","article-title":"Prognostic markers in triple-negative breast cancer","volume":"109","author":"Rakha","year":"2007","journal-title":"Cancer"},{"key":"R28-68-20210309","doi-asserted-by":"crossref","first-page":"R4","DOI":"10.1186\/bcr1636","article-title":"Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival","volume":"9","author":"Fulford","year":"2007","journal-title":"Breast Cancer Res"},{"key":"R29-68-20210309","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00000478-200002000-00005","article-title":"Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases","volume":"24","author":"Tsuda","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R30-68-20210309","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1158\/1078-0432.CCR-05-2281","article-title":"Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas","volume":"12","author":"Rodr\u00edguez-Pinilla","year":"2006","journal-title":"Clin Cancer Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:40:13Z","timestamp":1620960013000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711100-00068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":30,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008557","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}